Memphasys Ltd: Notification regarding unquoted securities - MEM
Memphasys Ltd: Application for quotation of securities - MEM
Memphasys Ltd: Bovine Study commences to assess RoXsta antioxidant system
Memphasys Ltd: Felix Clinical Registration Study completed, expanding mkt
Memphasys Ltd: Letter of Intent with Heranova for Felix System Distribution
Memphasys Ltd: Notification of cessation of securities - MEM
Memphasys Ltd: Order for Felix System to Evaluate Suitability in UAE
Memphasys Ltd: RoXsta System's Potential in Cattle Breeding being Explored
Memphasys Ltd: Second Supplementary Prospectus
Memphasys Ltd: Extension of convertible note
Memphasys Ltd: Final Director's Interest Notice - RC
Memphasys Ltd: Initial Director's Interest Notice - LE
Memphasys Ltd: Results of Meeting
Memphasys Ltd: Address to Shareholders
Memphasys Ltd: Chair Appointment/Resignation
Memphasys Ltd: Felix Clinical Trial Reaches 95% Completion
Memphasys Ltd: RoXsta System Secures Provisional Patent Approval
Memphasys Ltd: Notification regarding unquoted securities - MEM
Memphasys Ltd: Application for quotation of securities - MEM
Memphasys Ltd: Notification regarding unquoted securities - MEM
No Data